The US Food and Drug Administration (FDA) has proposed a rule that would establish a unified regulatory framework for tobacco product manufacturing practice requirements in the US.
The rule would apply to manufacturers of finished and bulk tobacco products.
One of the main reasons for proposing this rule is cases of variability in e-liquid nicotine concentrations where there is a contradiction between what the label states and the product’s actual nicotine level.
This report looks at how the rule came to be proposed, who and which products it would apply to, and when it would go into effect.
